185 related articles for article (PubMed ID: 9652345)
21. Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned alpha 1-adrenoceptor subtypes and in human prostate.
Michel MC; Grübbel B; Taguchi K; Verfürth F; Otto T; Kröpfl D
J Auton Pharmacol; 1996 Feb; 16(1):21-8. PubMed ID: 8736427
[TBL] [Abstract][Full Text] [Related]
22. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
Hussain MB; Marshall I
Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
[TBL] [Abstract][Full Text] [Related]
23. Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.
Meyer MD; Altenbach RJ; Bai H; Basha FZ; Carroll WA; Kerwin JF; Lebold SA; Lee E; Pratt JK; Sippy KB; Tietje K; Wendt MD; Brune ME; Buckner SA; Hancock AA; Drizin I
J Med Chem; 2001 Jun; 44(12):1971-85. PubMed ID: 11384242
[TBL] [Abstract][Full Text] [Related]
24. In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.
Williams TJ; Blue DR; Daniels DV; Davis B; Elworthy T; Gever JR; Kava MS; Morgans D; Padilla F; Tassa S; Vimont RL; Chapple CR; Chess-Williams R; Eglen RM; Clarke DE; Ford AP
Br J Pharmacol; 1999 May; 127(1):252-8. PubMed ID: 10369480
[TBL] [Abstract][Full Text] [Related]
25. Two district alpha(1)-adrenoceptor subtypes in the human prostate: assessment by radioligand binding assay using 3H-prazosin.
Maruyama K; Fukutomi J; Chiba T; Yamaguchi M; Takeda M; Hattori K; Nagatomo T
Gen Pharmacol; 1996 Dec; 27(8):1377-81. PubMed ID: 9304410
[TBL] [Abstract][Full Text] [Related]
26. Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists.
Hanft G; Gross G
Br J Pharmacol; 1989 Jul; 97(3):691-700. PubMed ID: 2569345
[TBL] [Abstract][Full Text] [Related]
27. The effects of SB 216469, an antagonist which discriminates between the alpha 1A-adrenoceptor and the human prostatic alpha 1-adrenoceptor.
Chess-Williams R; Chapple CR; Verfurth F; Noble AJ; Couldwell CJ; Michel MC
Br J Pharmacol; 1996 Nov; 119(6):1093-100. PubMed ID: 8937710
[TBL] [Abstract][Full Text] [Related]
28. Tamsulosin: alpha1-adrenoceptor subtype-selectivity and comparison with terazosin.
Muramatsu I; Taniguchi T; Okada K
Jpn J Pharmacol; 1998 Nov; 78(3):331-5. PubMed ID: 9869267
[TBL] [Abstract][Full Text] [Related]
29. Effects of desipramine on prazosin potency at α1A- and α1D-adrenoceptors in rat vas deferens: implications for the α1L-adrenoceptor subclassification.
Docherty JR
Eur J Pharmacol; 2014 Dec; 744():183-9. PubMed ID: 25446564
[TBL] [Abstract][Full Text] [Related]
30. Prazosin has low potency at α1A-adrenoceptors and high potency at α1D -adrenoceptors in rat vas deferens.
Docherty JR
Auton Autacoid Pharmacol; 2013 Oct; 33(3-4):49-57. PubMed ID: 24074250
[TBL] [Abstract][Full Text] [Related]
31. Selective enrichment with alpha 1A- and alpha 1B-adrenoceptor subtypes in rat brain cortical membranes.
Sallés J; Badia A
Eur J Pharmacol; 1994 Feb; 266(3):301-8. PubMed ID: 7909753
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic alpha1A- vs. alpha1B- and alpha1D-adrenoceptors.
Eltze M; Boer R; Michel MC; Hein P; Testa R; Ulrich WR; Kolassa N; Sanders KH
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):649-62. PubMed ID: 11414660
[TBL] [Abstract][Full Text] [Related]
33. Interaction of subtype-selective antagonists with alpha 1-adrenergic receptor binding sites in rat tissues.
Han CD; Minneman KP
Mol Pharmacol; 1991 Oct; 40(4):531-8. PubMed ID: 1681417
[TBL] [Abstract][Full Text] [Related]
34. Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3 -adrenoceptor activation and α1 -adrenoceptor blockade.
Alexandre EC; Kiguti LR; Calmasini FB; Silva FH; da Silva KP; Ferreira R; Ribeiro CA; Mónica FZ; Pupo AS; Antunes E
Br J Pharmacol; 2016 Feb; 173(3):415-28. PubMed ID: 26493129
[TBL] [Abstract][Full Text] [Related]
35. The antipsychotic drug sertindole is a specific inhibitor of alpha1A-adrenoceptors in rat mesenteric small arteries.
Ipsen M; Zhang Y; Dragsted N; Han C; Mulvany MJ
Eur J Pharmacol; 1997 Oct; 336(1):29-35. PubMed ID: 9384251
[TBL] [Abstract][Full Text] [Related]
36. Mediation of noradrenaline-induced contractions of rat aorta by the alpha 1B-adrenoceptor subtype.
Testa R; Guarneri L; Poggesi E; Simonazzi I; Taddei C; Leonardi A
Br J Pharmacol; 1995 Feb; 114(4):745-50. PubMed ID: 7773533
[TBL] [Abstract][Full Text] [Related]
37. Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat.
Blue DR; Bonhaus DW; Ford AP; Pfister JR; Sharif NA; Shieh IA; Vimont RL; Williams TJ; Clarke DE
Br J Pharmacol; 1995 May; 115(2):283-94. PubMed ID: 7670730
[TBL] [Abstract][Full Text] [Related]
38. Identification of the alpha1L-adrenoceptor in rat cerebral cortex and possible relationship between alpha1L- and alpha1A-adrenoceptors.
Morishima S; Suzuki F; Yoshiki H; Md Anisuzzaman AS; Sathi ZS; Tanaka T; Muramatsu I
Br J Pharmacol; 2008 Apr; 153(7):1485-94. PubMed ID: 18223667
[TBL] [Abstract][Full Text] [Related]
39. Effects of RS17053 on α
Alsufyani HA; Docherty JR
Fundam Clin Pharmacol; 2023 Dec; 37(6):1170-1178. PubMed ID: 37392126
[TBL] [Abstract][Full Text] [Related]
40. Ex vivo and in vivo alpha1-adrenoceptor binding characteristics of a novel alpha1L-adrenoceptor antagonist, JTH-601, in rat tissues.
Ohkura T; Yamada S; Tohma A; Kimura R; Aisaka K
Biol Pharm Bull; 1999 Jul; 22(7):687-90. PubMed ID: 10443463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
